Veracyte Inc

Veracyte Inc

VCYT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.96B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Veracyte IncVeracyte Inc15.2-9%3.5-
$56.56

Target Price by Analysts

132.5% upsideVeracyte Target Price DetailsTarget Price
$40.03

Current Fair Value

64.5% upside

Undervalued by 64.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.96 Billion
Enterprise Value$1.80 Billion
Earnings per Share$0.84
Beta1.96
Outstanding Shares80,500,406

Return

Return on Equity8.85%ROE
Return on Assets8.06%
Return on Invested Capital7.27%

Valuation & Multiples

P/E Ratio15.19P/E Ratio
PEG23.51PEG
Price to Sales3.48Price to Sales
Price to Book Ratio1.43Price to Book Ratio
Enterprise Value to Revenue3.09
Enterprise Value to EBIT16.63
Enterprise Value to Net Income14
Total Debt to Enterprise0.02
Debt to Equity0.03Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS
$0.51
Est. $0.41
Revenue
$151.75 M
Est. $147.13 M

Next Earnings Call

Expected Date
February 24, 2027
EPS Estimate
$0.39
Consensus analyst estimate
Revenue Estimate
$151.23 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 17.12%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %19.49%▼ 93.60%
Total Invested$715.08M▼ 86.47%
Investors Holding154▼ 225.00%

About Veracyte Inc

CEO: Bonnie Anderson

Veracyte Insider Information FAQ

Stockcircle tracks 7 top investors with a current 13F position in Veracyte. Notable holders include ARK Invest and Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 17 open-market insider sales for Veracyte in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Stockcircle lists 2 politician trade disclosures tied to Veracyte in the last twelve months, drawn from periodic financial disclosure reports. 1 politician traded Veracyte in the past year.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.